Skip to main content
. Author manuscript; available in PMC: 2022 Mar 14.
Published in final edited form as: J Biophotonics. 2021 May 4;14(7):e202100073. doi: 10.1002/jbio.202100073

Table 4.

Results of secondary endpoints

Treatment Group Treatment or Control Time Point Median Percent Change ([Baseline – 6 month]/Baseline)
POSAS- Patient Rating Group 1 Treatment Baseline 36.0 ↓66.7
6 month 12.0
Control Baseline 37.0 ↓71.6
6 month 10.5
Group 2 Treatment Baseline 32.0 ↓28.1
6 month 23.0
Control Baseline 30.5 ↓41.0
6 month 18.0
Group 3 Treatment Baseline 26.5 ↓50.9
6 month 13.0
Control Baseline 28.5 ↓40.4
6 month 17.0
POSAS- Observer Rating Group 1 Treatment Baseline 16.5 ↓45.5
6 month 9.0
Control Baseline 16.5 ↓24.2
6 month 12.5
Group 2 Treatment Baseline 19.0 ↓57.9
6 month 8.0
Control Baseline 14.0 0
6 month 14.0
Group 3 Treatment Baseline 18.0 ↓27.8
6 month 13.0
Control Baseline 16.5 ↓27.3
6 month 12.0
Collagen Group 1 Treatment Baseline 48.7 ↑17.0
6 month 57.0
Control Baseline 52.0 ↑8.7
6 month 56.5
Group 2 Treatment Baseline 51.0 ↑17.6
6 month 60.0
Control Baseline 50.5 ↑20.8
6 month 61.0
Group 3 Treatment Baseline 47.7 ↑18.9
6 month 56.7
Control Baseline 52.5 ↑13.0
6 month 59.3
Moisture (%) Group 1 Treatment Baseline 63.0 ↓0.8
6 month 62.5
Control Baseline 65.3 ↓6.3
6 month 61.2
Group 2 Treatment Baseline 60.7 ↑4.9
6 month 63.7
Control Baseline 62.7 ↑0.5
6 month 63.0
Group 3 Treatment Baseline 63.2 ↓1.9
6 month 62.0
Control Baseline 66.2 ↓3.3
6 month 64.0